🔗 Permalink

Inventor profile of:

Melanie Ott

City:

Mill Valley, California

Country:

United States

Published Applications:

Last publication date:

2026-01-29

Top Assignees for applications by Melanie Ott

The entities that hold a legal rights for patent applications filed by inventor Ott Melanie:

THE J. DAVID GLADSTONE INSTITUTES 5 San Francisco, CA United States
The Regents of the University of California 3 Oakland, CA United States
The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Gladstone 2 San Francisco, CA United States
The J. David Gladstone Institute, a testamentary trust established under the Will of J. David Gladstone 1 San Francisco, CA United States

Recent patent applications by Ott Melanie

Melanie Ott from Mill Valley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-29

US20260028599A1

Chemistry; metallurgy

EPIGENOME EDITORS FOR MODULATING HIV TRANSCRIPTION

#2 | 2025-12-18

US20250382658A1

Chemistry; metallurgy

HIV OR HCV DETECTION WITH CRISPR-CAS13A

#3 | 2025-12-04

US20250369058A1

Chemistry; metallurgy

Viral Diagnostic using CRISPR RNA combinations and Cas13a enzyme

#4 | 2024-09-26

US20240318266A1

Chemistry; metallurgy

HIGH-THROUGHPUT SCREENING OF SARS-COV-2 VARIANTS

#5 | 2024-09-19

US20240309473A1

Chemistry; metallurgy

KINETIC BARCODING TO ENHANCE SPECIFICITY OF CRISPR/CAS REACTIONS

#6 | 2024-09-05

US20240295544A1

Physics

ASSAY FOR SARS-CoV-2 INFECTION OF VULNERABLE HUMAN CELLS

#7 | 2024-06-27

US20240209381A1

Chemistry; metallurgy

RAPID GENERATION OF INFECTIOUS CLONES

#8 | 2022-06-23

US20220193209A1

Human necessities

COMPOSITIONS AND METHODS FOR REACTIVATING LATENT IMMUNODEFICIENCY VIRUS AND/OR TREATING IMMUNODEFICIENCY VIRUS INFECTION

#9 | 2022-03-24

US20220090085A1

Chemistry; metallurgy

Compositions and methods for reactivating latent immunodeficiency virus

#10 | 2021-11-11

US20210348243A1

Chemistry; metallurgy

RAPID FIELD-DEPLOYABLE DETECTION OF SARS-CoV-2 VIRUS

#11 | 2021-11-11

US20210348212A1

Chemistry; metallurgy

HIV or HCV detection with CRISPR-CAS13A

#12 | 2019-11-07

US20190338289A1

Chemistry; metallurgy

Compositions and methods for reactivating latent immunodeficiency virus

#13 | 2018-01-04

US20180002699A1

Chemistry; metallurgy

Compositions and methods for reactivating latent immunodeficiency virus

#14 | 2017-07-27

US20170209460A1

Human necessities

Compositions and methods for treating Dengue virus infection

#15 | 2015-05-14

US20150133434A1

Human necessities

Compositions and Methods for Reactivating Latent Immunodeficiency Virus

#16 | 2015-04-09

US20150098926A1

Human necessities

Methods of Treating Hepatitis C Virus Infection

#17 | 2014-01-30

US20140030295A1

Human necessities

Use of Sirt1 Activators or Inhibitors to Modulate an Immune Response

#18 | 2012-05-03

US20120108500A1

Human necessities

Compositions and Methods for Modulating Immunodeficiency Virus Transcription

#19 | 2011-12-29

US20110318377A1

Chemistry; metallurgy

Screening method for the identification of inhibitors of HIV Tat methylation by the lysine methyltransferase Set7/9

#20 | 2011-10-06

US20110243894A1

Human necessities

METHODS OF TREATING HEPATITIS C VIRUS INFECTION

InventorID:

630929 ⎘